ArticleCancer biology & therapy2019

Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition.

Rashid Gabbasov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.